Chronic Myeloid Leukemia (CML) Real-Life Database
ConditionChronic Myeloid Leukemia (CML)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversity Hospital, Clermont-Ferrand
About this trial
Establish the largest possible real-life cohort collecting long-term follow-up of a maximum number of CML patients in order to carry out observational studies: epidemiological, identification of subgroups according to their response to treatment, evaluation of new molecules in real life, therapeutic discontinuations, impact of the evolution of recommendations, etc.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patient diagnosed for chronic myelocytic leukemia
Disqualifiers
CML allograft without TKI treatment
Refusal or inability to sign the consent
Trial population
Any patient with a diagnose of CML
Trial design
Design model
Cohort
Time perspective
Other
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Clinical and biological data collection
Aims of the registry are the collection of clinical data to gain further insights about patients's CML treated with ITK's (treatment, prognosis, therapeutical response).
Time frame
Until death or last follow up (up to 30 years)Secondary outcomes
1
Prognosis score for CML (Sokal, ELTS, Eutos, Hasford)
Time frame
At diagnosis2
BMI with evaluation of weight and height
Time frame
Until death or last follow up (up to 30 years)3
Evaluation of major molecular response (MMR) with transcript BCR::ABL in %
Time frame
Until death or last follow up (up to 30 years)4
Evaluation of molecular response MR4 with transcript BCR::ABL in %
Time frame
Until death or last follow up (up to 30 years)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University Hospital, Clermont-Ferrand
Lead sponsor
Centre Hospitalier Universitaire de Saint Etienne
Collaborator
Bicetre Hospital
Collaborator
University Hospital, Caen
Collaborator
Central Hospital, Nancy, France
Collaborator
University Hospital, Toulouse
Collaborator
CH Annecy Genevois
Collaborator
Rennes University Hospital
Collaborator
Hopital Paul Brousse
Collaborator
Versailles Hospital
Collaborator
Centre Hospitalier Emile Roux
Collaborator
University Hospital, Limoges
Collaborator
Institut Paoli-Calmettes
Collaborator
Centre Hospitalier de Rochefort
Collaborator
Source ClinicalTrials.gov